Large changes in urinary pH caused by the concurrent use of alkalinising drugs such as acetazolamide can, in some patients, have a marked effect on the plasma levels of mexiletine.
The effect does not appear to be predictable. The manufacturer of mexiletine recommends that concurrent use should be avoided.
© 2006-2023 Last Updated On: 01/26/2023 (0)
Wait 20 seconds...!!!